Imbria Pharmaceuticals (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- April 10, 2025
- Vertical
- Pharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $57,500,000
Company Info
- Founders
- Alvin Shih, MD
- Company Description
- Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.
- Market
- Cardiometabolic disorders
- Location
- Boston, MA, USA
- Coinvestors
- BAN Ventures, Catalio Capital, Cytokinetics, Deep Track Capital, RA Capital Management, SV Health Investors